TriplePoint Venture Growth BDC Corporation (TPVG)
Stock Price Chart
Key Info
| Market Cap | 384.19M |
| Revenue (ttm) | 79.88M |
| Net Income (ttm) | 12.93M |
| Shares Out | 30.78M |
| EPS (ttm) | 0.47 |
| PE Ratio | 26.55 |
| Forward PE | 8.77 |
| Dividend | $1.44 |
| Dividend Yield | 11.54% |
Stock Quote
| Trading Day | Aug 13, 2020 |
| Last Price | $12.48 |
| Previous Close | $12.41 |
| Change ($) | 0.07 |
| Change (%) | 0.56% |
| Day's Open | 12.41 |
| Day's Range | 12.33 - 12.52 |
| Day's Volume | 159,028 |
| 52-Week Range | 2.80 - 17.17 |
More Stats
| Market Cap | 384.19M |
| Enterprise Value | 661.99M |
| Earnings Date (est) | Nov 9, 2020 |
| Ex-Dividend Date | Jun 15, 2020 |
| Shares Outstanding | 30.78M |
| Float | n/a |
| EPS (basic) | 0.4 |
| EPS (diluted) | 0.47 |
| FCF / Share | -5.93 |
| Dividend | $1.44 |
| Dividend Yield | 11.54% |
| Earnings Yield | 3.77% |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 254,603 |
| Short Ratio | 1.36 |
| Short % of Float | 0.84% |
| Beta | 1.89 |
| PE Ratio | 26.55 |
| Forward PE | 8.77 |
| P/FCF Ratio | n/a |
| PS Ratio | 4.81 |
| PB Ratio | 0.94 |
| Revenue | 79.88M |
| Operating Income | 57.65M |
| Net Income | 12.93M |
| Free Cash Flow | -182.27M |
| Net Cash | -277.81M |
| Net Cash / Share | -9.02 |
| Gross Margin | 89.73% |
| Operating Margin | 72.17% |
| Profit Margin | 15.80% |
| FCF Margin | -228.17% |
| ROA | 5.79% |
| ROE | 3.41% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 73.39 | 64.65 | 51.51 | 43.64 | 42.09 |
| Revenue Growth | 13.52% | 25.51% | 18.05% | 3.68% | - |
| Gross Profit | 56.70 | 49.03 | 39.63 | 35.34 | 32.30 |
| Operating Income | 50.66 | 44.07 | 35.33 | 30.87 | 28.24 |
| Net Income | 31.76 | 36.56 | 19.23 | 11.13 | 15.52 |
| Shares Outstanding | 24.84 | 20.49 | 16.32 | 16.16 | 15.04 |
| Earnings Per Share | 1.28 | 1.78 | 1.18 | 0.69 | 1.03 |
| EPS Growth | -28.09% | 50.85% | 71.01% | -33.01% | - |
| Dividend Per Share | 1.44 | 1.54 | 1.44 | 1.44 | 1.44 |
| Dividend Growth | -6.49% | 6.94% | 0% | 0% | - |
| Operating Cash Flow | -188 | -17.82 | 25.10 | -92.01 | 0.14 |
| Free Cash Flow | -188 | -17.82 | 25.10 | -92.01 | 0.14 |
| Cash & Equivalents | 26.44 | 9.95 | 10.01 | 15.48 | 38.48 |
| Total Debt | 336 | 95.94 | 139 | 168 | 70.91 |
| Net Cash / Debt | -309 | -85.99 | -129 | -153 | -32.43 |
| Assets | 684 | 467 | 510 | 434 | 382 |
| Liabilities | 352 | 133 | 275 | 218 | 151 |
| Book Value | 333 | 335 | 235 | 216 | 232 |
Company Profile
Company Details
| Full Name | TriplePoint Venture Growth BDC Corporation |
| Country | United States |
| CEO | Jim P. Labe |
Stock Information
| Ticker Symbol | TPVG |
| Stock Exchange | New York Stock Exchange |
| Sector | Financial Services |
| Industry | Asset Management |
| Unique Identifier | NYSE: TPVG |
Description
TriplePoint Venture Growth BDC Corp is a business development company specializing investments in growth stage. It also provides debt financing to venture growth space companies which includes growth capital loans, equipment financings, revolving loans, and direct equity investments. The fund seeks to invest in e-commerce, entertainment, technology and life sciences sector. Within technology the areas of focus include: Security, wireless communication equipments, network system and software, business applications software, conferencing equipments/services .big data, cloud computing, data storage, electronics, energy efficiency, hardware, information services, internet and media, networking, semiconductors, software, software as a service, and other technology related subsectors and within life sciences the areas of focus include: biotechnology, bio fuels/bio mass, diagnostic testing and bioinformatics, drug delivery, drug discovery, healthcare information systems, healthcare services, medical, surgical and therapeutic devices, pharmaceuticals and other life science related subsectors. Within growth capital loans it invests between $5 million and $50 million, for equipment financings it invests between $5 million and $25 million, for revolving loans it invests between $1 million and $25 million, and for direct equity investments it may invest between $0.1 million and $5 million (generally not exceeding 5% of the company's total equity). The debt financing products are typically structured as lines of credit and it invests through warrants and secured loans. It does not take board seat in the company.